Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.

Drylewicz J, Schellens IM, Gaiser R, Nanlohy NM, Quakkelaar ED, Otten H, van Dorp S, Jacobi R, Ran L, Spijkers S, Koning D, Schuurman R, Meijer E, Pietersma FL, Kuball J, van Baarle D.

J Transl Med. 2016 Aug 2;14(1):230. doi: 10.1186/s12967-016-0988-4.

2.

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia.

Scheper W, van Dorp S, Kersting S, Pietersma F, Lindemans C, Hol S, Heijhuurs S, Sebestyen Z, Gründer C, Marcu-Malina V, Marchant A, Donner C, Plachter B, Vermijlen D, van Baarle D, Kuball J.

Leukemia. 2013 Jun;27(6):1328-38. doi: 10.1038/leu.2012.374. Epub 2013 Jan 1.

PMID:
23277330
3.

Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient.

Pietersma FL, van Oosterom A, Ran L, Schuurman R, Meijer E, de Jonge N, van Baarle D.

Transpl Immunol. 2012 Aug;27(1):48-51. doi: 10.1016/j.trim.2012.02.001. Epub 2012 Feb 10.

PMID:
22342937
4.

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.

van Dorp S, Resemann H, te Boome L, Pietersma F, van Baarle D, Gmelig-Meyling F, de Weger R, Petersen E, Minnema M, Lokhorst H, Ebeling S, Beijn SJ, Knol EF, van Dijk M, Meijer E, Kuball J.

Haematologica. 2011 Sep;96(9):1380-4. doi: 10.3324/haematol.2011.041814. Epub 2011 May 5.

5.

Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients.

Pietersma FL, van Dorp S, Minnema MC, Kuball J, Meijer E, Schuurman R, van Baarle D.

Clin Infect Dis. 2011 Apr 1;52(7):e144-8. doi: 10.1093/cid/cir002.

PMID:
21427386
6.

High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults.

Pietersma FL, van Dorp S, Jacobi R, Ran L, Nanlohy NM, Schuurman R, Minnema MC, Meijer E, van Baarle D.

Clin Infect Dis. 2010 Mar 1;50(5):717-25. doi: 10.1086/650455.

PMID:
20121571
7.

Rituximab treatment before reduced-intensity conditioning transplantation associates with a decreased incidence of extensive chronic GVHD.

van Dorp S, Pietersma F, Wölfl M, Verdonck LF, Petersen EJ, Lokhorst HM, Martens E, Theobald M, van Baarle D, Meijer E, Kuball J.

Biol Blood Marrow Transplant. 2009 Jun;15(6):671-8. doi: 10.1016/j.bbmt.2009.02.005. Epub 2009 Apr 16.

8.

Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.

Pietersma F, Piriou E, van Baarle D.

Leuk Lymphoma. 2008 Jun;49(6):1028-41. doi: 10.1080/10428190801911662. Review.

PMID:
18452077

Supplemental Content

Loading ...
Support Center